Works matching IS 10837159 AND DT 2021 AND VI 26 AND IP 4
Results: 39
An Homage to Two Explorers of Uncharted Cancer Waters.
- Published in:
- 2021
- By:
- Publication type:
- Obituary
Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 288, doi. 10.1002/onco.13712
- By:
- Publication type:
- Article
Feasibility and Predictive Performance of a Triage System for Patients with Cancer During the COVID‐19 Pandemic.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e694, doi. 10.1002/onco.13706
- By:
- Publication type:
- Article
FOLFOXIRI plus Bevacizumab Versus FOLFOX plus Panitumumab for Metastatic Left‐Sided RAS/BRAF Wild‐Type Colorectal Cancer: Which "Side" Are You On?
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 277, doi. 10.1002/onco.13705
- By:
- Publication type:
- Article
KRAS‐Mutated, Estrogen Receptor‐Positive Low‐Grade Serous Ovarian Cancer: Unraveling an Exceptional Response Mystery.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e530, doi. 10.1002/onco.13702
- By:
- Publication type:
- Article
Cancer of Unknown Primary Presenting as Bone‐Predominant or Lymph Node‐Only Disease: A Clinicopathologic Portrait.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e650, doi. 10.1002/onco.13700
- By:
- Publication type:
- Article
Caregiver–Oncologist Prognostic Concordance, Caregiver Mastery, and Caregiver Psychological Health and Quality of Life.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 310, doi. 10.1002/onco.13699
- By:
- Publication type:
- Article
Landscape of Cyclin Pathway Genomic Alterations Across 5,356 Prostate Cancers: Implications for Targeted Therapeutics.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e715, doi. 10.1002/onco.13694
- By:
- Publication type:
- Article
Selinexor, a First in Class, Nuclear Export Inhibitor for the Treatment of Advanced Malignant Peripheral Nerve Sheath Tumor.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e710, doi. 10.1002/onco.13692
- By:
- Publication type:
- Article
Does Scalp Cooling Have the Same Efficacy in Black Patients Receiving Chemotherapy for Breast Cancer?
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 292, doi. 10.1002/onco.13690
- By:
- Publication type:
- Article
Remember Your Why: An Oncologist's Reflections on Running During the COVID‐19 Pandemic.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 348, doi. 10.1002/onco.13683
- By:
- Publication type:
- Article
Emergency Department Visits for Emesis Following Chemotherapy: Guideline Nonadherence, OP‐35, and a Path Back to the Future.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 274, doi. 10.1002/onco.13681
- By:
- Publication type:
- Article
Reconsidering Dexamethasone for Antiemesis when Combining Chemotherapy and Immunotherapy.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 269, doi. 10.1002/onco.13680
- By:
- Publication type:
- Article
Rapid Implementation of Telemedicine During the COVID‐19 Pandemic: Perspectives and Preferences of Patients with Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e679, doi. 10.1002/onco.13676
- By:
- Publication type:
- Article
Avapritinib in Patients With Advanced Gastrointestinal Stromal Tumors Following at Least Three Prior Lines of Therapy.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e639, doi. 10.1002/onco.13674
- By:
- Publication type:
- Article
Novel Tumor Growth Rate Analysis in the Randomized CLARINET Study Establishes the Efficacy of Lanreotide Depot/Autogel 120 mg with Prolonged Administration in Indolent Neuroendocrine Tumors.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e632, doi. 10.1002/onco.13669
- By:
- Publication type:
- Article
Prevalence and Clinical Impact of SARS‐CoV‐2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID‐19 Pandemic.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 341, doi. 10.1002/onco.13654
- By:
- Publication type:
- Article
Benefit–Risk Summary of Nivolumab for the Treatment of Patients with Unresectable Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma After Prior Fluoropyrimidine‐ and Platinum‐Based Chemotherapy.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 318, doi. 10.1002/onco.13646
- By:
- Publication type:
- Article
Analysis of the Role of Plasma 25‐Hydroxyvitamin D Levels in Survival Outcomes in Patients from the Phase III MPACT Trial of Metastatic Pancreatic Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e704, doi. 10.1002/onco.13645
- By:
- Publication type:
- Article
FOLFOXIRI‐Bevacizumab or FOLFOX‐Panitumumab in Patients with Left‐Sided RAS/BRAF Wild‐Type Metastatic Colorectal Cancer: A Propensity Score‐Based Analysis.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 302, doi. 10.1002/onco.13642
- By:
- Publication type:
- Article
Current Status of Advance Care Planning and End‐of‐life Communication for Patients with Advanced and Metastatic Breast Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e686, doi. 10.1002/onco.13640
- By:
- Publication type:
- Article
Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision‐Making for Patients with Advanced Solid Tumors.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e588, doi. 10.1002/onco.13639
- By:
- Publication type:
- Article
ADAURA: Mature Enough for Publication, Not for Prime Time.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 266, doi. 10.1002/onco.13637
- By:
- Publication type:
- Article
Adjuvant Osimertinib: A New Standard of Care.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 263, doi. 10.1002/onco.13634
- By:
- Publication type:
- Article
Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki‐67 Is ≥10%?
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 294, doi. 10.1002/onco.13633
- By:
- Publication type:
- Article
Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e622, doi. 10.1002/onco.13632
- By:
- Publication type:
- Article
Phase I Study of Afatinib and Selumetinib in Patients with KRAS‐Mutated Colorectal, Non‐Small Cell Lung, and Pancreatic Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 290, doi. 10.1002/onco.13631
- By:
- Publication type:
- Article
A European, Observational, Prospective Trial of Trabectedin Plus Pegylated Liposomal Doxorubicin in Patients with Platinum‐Sensitive Ovarian Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e658, doi. 10.1002/onco.13630
- By:
- Publication type:
- Article
Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e608, doi. 10.1002/onco.13627
- By:
- Publication type:
- Article
Implementing DPYD*2A Genotyping in Clinical Practice: The Quebec, Canada, Experience.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e597, doi. 10.1002/onco.13626
- By:
- Publication type:
- Article
Timing of Palliative Care Referral Before and After Evidence from Trials Supporting Early Palliative Care.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 332, doi. 10.1002/onco.13625
- By:
- Publication type:
- Article
Avoidable Acute Care Use Associated with Nausea and Vomiting Among Patients Receiving Highly Emetogenic Chemotherapy or Oxaliplatin.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 325, doi. 10.1002/onco.13620
- By:
- Publication type:
- Article
Assessing the Quality of Care Delivered to Transgender and Gender Diverse Patients with Cancer in Ireland: A Case Series.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e603, doi. 10.1002/onco.13618
- By:
- Publication type:
- Article
Phase I Dose‐Escalation Study of SCB01A, a Microtubule Inhibitor with Vascular Disrupting Activity, in Patients with Advanced Solid Tumors.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e567, doi. 10.1002/onco.13612
- By:
- Publication type:
- Article
A Phase Ib Study of NUC‐1031 in Combination with Cisplatin for the First‐Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC‐08).
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e669, doi. 10.1002/onco.13598
- By:
- Publication type:
- Article
Everolimus‐Related Pneumonitis in Patients with Metastatic Breast Cancer: Incidence, Radiographic Patterns, and Relevance to Clinical Outcome.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e580, doi. 10.1002/onco.13594
- By:
- Publication type:
- Article
A Phase I Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Ipilimumab in Chinese Patients with Select Advanced Solid Tumors.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e549, doi. 10.1002/onco.13577
- By:
- Publication type:
- Article
Metastatic Low‐Grade Sarcoma with CARS‐ALK Fusion Dramatically Responded to Multiple ALK Tyrosine Kinase Inhibitors: A Case Report with Comprehensive Genomic Analysis.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e524, doi. 10.1002/onco.13543
- By:
- Publication type:
- Article
Clinical Benefit of Tyrosine Kinase Inhibitors in Advanced Lung Cancer with EGFR‐G719A and Other Uncommon EGFR Mutations.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 281, doi. 10.1002/onco.13537
- By:
- Publication type:
- Article